Grant: CECR - Centres of Excellence for Commercialization and Research
Centre for Commercialization of Cancer Immunotherapy
$512,000.00
C3i - Centre for Commercialization of Cancer Immunotherapy / C3i - Centre de commercialisation en Immunothérapie du Cancer
EF 2018-19
Programme
CECR - Centres of Excellence for Commercialization and Research
Emplacement
Quebec, Canada
Type
Grant
Source
SSHRC's Expenditures File
Tel que publié
Cle
74203
Name nom
Hôpital Maisonneuve-Rosemont
Role rôle
Institution-Based Application
Amount montant
$512,000
Fiscal year exercice financier
2018
Institution
Centre for Commercialization of Cancer Immunotherapy
Établissement
Centre for Commercialization of Cancer Immunotherapy
Province id
QC
Province en
Québec
Province fr
Québec
Competition year année du concours
2015
Title titre
C3i - Centre for Commercialization of Cancer Immunotherapy / C3i - Centre de commercialisation en Immunothérapie du Cancer
Keywords mots clés
cancer; immunotherapy; PD-1; next generation sequencing; GMP; lean; cell therapy; GMP clinical research; biomarkers; commercialization
Program
CECR - Centres of Excellence for Commercialization and Research
Programme
CECR - Centres d'excellence en commercialisation et en recherche
Discipline en
Not specified
Discipline fr
Non précisé
Main discipline
Not specified
Discipline principale
Non précisé
Area of research
Health
Domaine de recherche
Santé
